Skip to main content

Artiva Biotherapeutics, Inc.

ARTV
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001817241

In the last 90 days, Artiva Biotherapeutics, Inc. insiders filed 5 open-market purchases and 7 sales; 72 institutions reported holding it in 13F filings for Q2 2026, worth $391.6M in total; Viking Global Investors is the only superinvestor holding it.

13F holders, Q4 2024

Institutional positions in Artiva Biotherapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
57
+8 vs. Q3 2024
Shares held
21.2M
+431.8K (+2.1%) vs. Q3 2024
Total value
$213.2M
−$106.1M (−33.2%) vs. Q3 2024
New holders
9
18 more added
Sold out
1
6 more reduced

Compare with Q3 2024: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting ARTV on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ4 2024: 57 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 0 institutionsQ3 2022: 0 institutionsQ4 2022: 0 institutionsQ1 2023: 0 institutionsQ2 2023: 0 institutionsQ3 2023: 0 institutionsQ4 2023: 0 institutionsQ1 2024: 0 institutionsQ2 2024: 0 institutionsQ3 2024: 49 institutionsQ4 2024: 57 institutionsQ1 2025: 53 institutionsQ2 2025: 48 institutionsQ3 2025: 40 institutionsQ4 2025: 34 institutionsQ1 2026: 40 institutionsQ2 2026: 72 institutions
Value heldQ4 2024: $213.2M
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $0Q3 2022: $0Q4 2022: $0Q1 2023: $0Q2 2023: $0Q3 2023: $0Q4 2023: $0Q1 2024: $0Q2 2024: $0Q3 2024: $319.4MQ4 2024: $213.2MQ1 2025: $62.8MQ2 2025: $27.9MQ3 2025: $52.1MQ4 2025: $72.7MQ1 2026: $108.4MQ2 2026: $391.6M
Institutions holding ARTV and their total value by quarter
QuarterHoldersValue
Q2 202672$391.6M
Q1 202640$108.4M
Q4 202534$72.7M
Q3 202540$52.1M
Q2 202548$27.9M
Q1 202553$62.8M
Q4 202457$213.2M
Q3 202449$319.4M
Q2 20240$0
Q1 20240$0
Q4 20230$0
Q3 20230$0
Q2 20230$0
Q1 20230$0
Q4 20220$0
Q3 20220$0
Q2 20220$0
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q4 2024

Shares, value and share of portfolio for each institution holding Artiva Biotherapeutics, Inc.; share changes are against Q3 2024.

Institutions holding ARTV in Q4 2024
InstitutionSharesValue% of portfolioChange in sharesAction
Ra Capital Management, L.P.9,853,302$99.3M1.32%00.0%Unchanged
5AM Venture Management, LLC2,353,304$23.7M5.66%00.0%Unchanged
VR Adviser, LLC1,609,569$16.2M1.11%00.0%Unchanged
venBio Partners LLC1,519,971$15.3M8.98%00.0%Unchanged
BlackRock, Inc.1,046,353$10.5M0.00%+208,740+24.9%Added
Capital World Investors915,386$9.23M0.00%00.0%Unchanged
Vanguard Group Inc866,925$8.74M0.00%+25,920+3.1%Added
Franklin Resources Inc520,301$5.24M0.00%00.0%Unchanged
Geode Capital Management, LLC315,758$3.18M0.00%+6,828+2.2%Added
Samsara BioCapital, LLC291,666$2.94M0.40%00.0%Unchanged
Woodline Partners LP283,124$2.85M0.02%00.0%Unchanged
Wellington Management Group LLP194,108$1.95M0.00%00.0%Unchanged
State Street Corp164,783$1.66M0.00%+78,224+90.4%Added
RTW Investments, LP148,844$1.50M0.02%00.0%Unchanged
Logos Global Management LP145,089$1.46M0.17%00.0%Unchanged
Northern Trust Corp117,112$1.18M0.00%+4,335+3.8%Added
Cormorant Asset Management, LP103,633$1.04M0.06%00.0%Unchanged
Alyeska Investment Group, L.P.100,000$1.01M0.00%00.0%Unchanged
Citadel Advisors LLC103,635$992.4K0.00%00.0%Unchanged
Acuta Capital Partners, LLC44,000$443.5K0.45%00.0%Unchanged
Charles Schwab Investment Management Inc43,526$438.7K0.00%+3,233+8.0%Added
EcoR1 Capital, LLC41,453$417.8K0.02%00.0%Unchanged
Goldman Sachs Group Inc38,070$383.7K0.00%+8,523+28.8%Added
JPMorgan Chase & Co37,619$379.2K0.00%+26,893+250.7%Added
Morgan Stanley37,287$375.9K0.00%−2,666−6.7%Reduced
UBS Group AG35,379$356.6K0.00%+28,761+434.6%Added
Bank of New York Mellon Corp33,305$335.7K0.00%+2,096+6.7%Added
Norges Bank30,000$302.4K0.00%00.0%Unchanged
Barclays PLC24,161$243.5K0.00%+4,545+23.2%Added
Deutsche Bank AG21,423$215.9K0.00%+21,423New
Nuveen Asset Management, LLC18,611$187.6K0.00%00.0%Unchanged
Citigroup Inc15,606$157.3K0.00%+5,425+53.3%Added
Rhumbline Advisers12,879$129.8K0.00%−1,950−13.1%Reduced
Bank of America Corp10,817$109.0K0.00%−7,001−39.3%Reduced
BNP Paribas Arbitrage, SA9,879$99.6K0.00%+7,151+262.1%Added
MetLife Investment Management8,733$88.0K0.00%00.0%Unchanged
Wells Fargo & Company8,616$86.8K0.00%+3,361+64.0%Added
Mirae Asset Global ETFs Holdings Ltd.8,039$81.0K0.00%+380+5.0%Added
Corebridge Financial, Inc.7,289$73.5K0.00%−226−3.0%Reduced
China Universal Asset Management Co., Ltd.5,150$51.9K0.00%+5,150New
Police & Firemen's Retirement System of New Jersey3,477$35.0K0.00%+3,477New
New York State Common Retirement Fund2,937$29.6K0.00%00.0%Unchanged
Ameritas Investment Partners, Inc.1,424$14.4K0.00%00.0%Unchanged
Legal & General Group Plc1,393$14.0K0.00%00.0%Unchanged
Tower Research Capital LLC (TRC)1,212$12.2K0.00%+492+68.3%Added
Royal Bank of Canada1,106$11.0K0.00%−955−46.3%Reduced
California State Teachers Retirement System1,041$10.5K0.00%00.0%Unchanged
Mark Sheptoff Financial Planning, LLC900$9.07K0.00%−400−30.8%Reduced
FMR LLC900$9.07K0.00%+740+462.5%Added
Mirae Asset Global Investments Co., Ltd.809$8.61K0.00%+809New
GF Fund Management Co. Ltd.510$5.14K0.00%+510New
Amalgamated Bank480$5.00K0.00%00.0%Unchanged
Nelson, Van Denburg & Campbell Wealth Management Group, LLC224$2.26K0.00%+224New
Sterling Capital Management LLC216$2.18K0.00%+185+596.8%Added
CWM, LLC132$1.00K0.00%+132New
Nisa Investment Advisors, LLC43$4330.00%+43New
GAMMA Investing LLC15$1510.00%+15New
STRS Ohio0$00.00%−2,600−100.0%Sold out